Table 4.
OSA-MA score for DHA/EPA and placebo treatment groups.
| Variable | Baseline | Week 12 | ||||
|---|---|---|---|---|---|---|
| DHA/EPA Group (n = 33) | Placebo Group (n = 33) | p Value | DHA/EPA Group (n = 33) | Placebo Group (n = 33) | p Value | |
| Sleepiness on rising | 14.3 ± 5.1 | 14.3 ± 5.1 | 0.998 | 17.7 ± 5.4 | 18.5 ± 5.5 | 0.488 |
| Initiation and maintenance of sleep | 12.9 ± 5.3 | 13.3 ± 4.3 | 0.792 | 16.7 ± 4.9 | 17.9 ± 5.0 | 0.351 |
| Frequent dreaming | 20.1 ± 8.0 | 21.0 ± 7.5 | 0.647 | 24.4 ± 4.1 * | 22.2 ± 6.4 | 0.043 |
| Refreshing on rising | 14.9 ± 3.9 | 15.0 ± 4.9 | 0.974 | 19.2 ± 5.5 | 20.0 ± 4.8 | 0.451 |
| Sleep length | 16.5 ± 4.7 | 15.1 ± 4.1 | 0.194 | 18.6 ± 4.6 | 19.2 ± 5.4 | 0.125 |
* p < 0.05.